Puma Biotechnology financial statements

퓨마 바이오테크놀로지NASDAQ:PBYI · Nasdaq · Healthcare · sector #16
$9.50-1.76%
2026-10-06 close · prelim

Puma Biotechnology's published financial data is dated 2026-10-04. 2024 revenue was $230M. 2024 operating profit was $31M.

Reported results

Puma Biotechnology notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q